Recent advances in biotechnology are helping us prepare for and meet societys most pressing challenges.

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes.

Currently, there are more than 250 biotechnology health care products and vaccines available to patients, many for previously untreatable diseases. More than 18 million farmers around the world use agricultural biotechnology to increase yields, prevent damage from insects and pests and reduce farming's impact on the environment. And more than 50 biorefineries are being built across North America to test and refine technologies to produce biofuels and chemicals from renewable biomass, which can help reduce greenhouse gas emissions.

Recent advances in biotechnology are helping us prepare for and meet societys most pressing challenges. Here's how:

Biotech is helping toheal the worldby harnessing nature's own toolbox and using our own genetic makeup to heal and guide lines of research by:

Biotech uses biological processes such as fermentation and harnesses biocatalysts such as enzymes, yeast, and other microbes to become microscopic manufacturing plants. Biotech is helping tofuel the worldby:

Biotech improves crop insect resistance, enhances crop herbicide tolerance and facilitates the use of more environmentally sustainable farming practices. Biotech is helping tofeed the worldby:

Source: Healing, Fueling, Feeding: How Biotechnology is Enriching Your Life

See the article here:
biotechnology - BIO | Healing, Fueling and Feeding the World

The biotechnology program at Ivy Tech is taught by instructors with real-world experience. Students will use state-of-the-art laboratories that are equipped with instrumentation, supplies and equipment for an effective hands-on laboratory experience.

Classes focus on teaching a variety of procedures necessary to execute laboratory projects assigned in the students chosen field. Students will spend a significant amount of class time working hands-on doing laboratory activities either by themselves or in small groups with the ability to have one-on-one time with the instructor.

The Biotechnology Program prepares students for careers in a variety of life science and manufacturing settings including research, quality control, pharmaceuticals, and medical devise manufacturing.

Graduates will have the foundation needed to transfer to earn a bachelors degree or move right in to local, high-paying jobs in the community, including with some of our industry partners like Dow Agroscience, Eli Lilly, Cook Pharmica, Midwest Compliance Laboratories, and more. These great partnerships lead to our graduates high job placement rate.

*According to a Battelle/Biotechnology Industry Organization (BIO) Report State Biosciences Jobs, Investments and Innovation 2014.

Continued here:
Biotechnology - Ivy Tech Community College of Indiana

From the United States to Kenya, food biotechnology can deliver major benefits
Video courtesy of FoodInsightTV https://www.youtube.com/channel/UCn2k5w1PhSWv_umuKmQkHrQ.

By: DonParavacinni

Read the original:
From the United States to Kenya, food biotechnology can deliver major benefits - Video

Top 10 biotech companies in India 1. Biocon Established in the year 1978 Biocon, global biopharmaceutical enterprise is actively involved in the manufacturing and development of innovative technologies that includes large-scale chemical synthesis, microbial fermentation, mammalian cell culture, purification of protein & antibody and various aseptic formulations. Chairman Kiran Mazumdar-Shaw; Corporate Office Bangalore, India | Sector Private | Website http://www.biocon.com 2. Serum Institute of India Serum Institute of India Ltd. established in the year 1966 is the world's largest producer of Measles and DTP group of vaccines. The company manufactures life-saving Biologicals including Anti-Snake Venom and Tetanus Antitoxin serum, DTP (Diphtheria, Tetanus and Pertussis) and MMR (Measles, Mumps and Rubella) group of vaccines at affordable prices. Chairman Cyrus S. Poonawalla; Location: Pune, India | Sector Private | Website http://www.seruminstitute.com 3. Panacea Biotech Ltd Panacea Biotec established in the year 1976, has strong R and D capabilities with a wide range of pipeline including: Development various complex pharmaceutical generic compounds Technologies) Development of New Chemical Entities (NCE) Vaccines Chairman Soshil Kumar, Corporate Office New Delhi, India | | Business Pharmaceutical, Biotechnology | Sector Private | Website http://www.panacea-biotec.com 4. Novo Nordisk Established in the year 1923, Novo Nordisk is the worlds leader in diabetes care, manufacturing broadest diabetes product that includes development of the most advanced products related to insulin delivery systems. Chairman Sten Scheibye, Corporate Office Denmark, Business -Sector Pharmaceutical- Private | Website http://www.novonordisk.co.in 5. GlaxoSmithKline Pharmaceuticals Ltd. One of the earliest pharmaceutical companies in India is GSK India. It was established in the year 1924. The GSK India is an important group of manufacturing products of wide range of prescription medicines and vaccines in therapeutic areas such as dermatology, anti-infectives, diabetes, oncology, cardiovascular and respiratory diseases. The company also manufactures vaccines for prevention of hepatitis A and B, invasive diseases caused by H. influenzae, chickenpox, DPT, cervical cancer, rotavirus, Streptococcal pneumonia etc. Chairman Chris Gent; Corporate Office London, United Kingdom Business Biotechnology and Pharmaceutical, Sector Private | Website http://www.gsk-india.com 6. SIRO Clinpharm Established in the year 1996 the company provides a wide range of services including Clinical Operations & Clinical Monitoring, Clinical Data management, medical and scientific writing, biostatistics and statistical programming, clinical trial supplies management, pharmacovigilance. Chairman Dr. Gautam Daftary; Corporate Office Thane, India | | | Business Drug Development; Sector Private | Website http://www.siroclinpharm.com 7. Novozymes, South Asia Novozymes a biotech company established in 1925 strongly focus on production of novel enzymes. The companys biosolution provides everything from the removal of trans fats in food to advancements in bioenergy sources. Chairman Kbenhavns Lufthavne; Corporate Office Bagsvaerd, Denmark; Novozymes South Asia Pvt. Ltd. Bangalore, India; Sector Private | Website http://www.novozymes.com 8. Zydus Cadila Zydus Cadila, established in the year 1952, is a fully integrated, global healthcare company with complete healthcare solutions ranging from active pharmaceutical ingredients, formulations products related to animal health care to wellness products. The company is the only Indian pharma establishment that launched the worlds first drug NCE Lipaglyn for treatment of diabetic dyslipidemia. Chairman - Mr. Pankaj R. Patel, Corporate office-Ahmedabad, Sector- Private Website- http://www.zyduscadila.com 9. Indian Immunologicals Indian Immunologicals Ltd. (IIL) was established in 1982 by The National Dairy Development Board (NDDB) with the focus to manufacture Foot and Mouth Disease (FMD) vaccine available to poor people at an affordable price. IIL provides a range of adult as well as child vaccines. Chairman Dr. Amrita Patel; Corporate Office Hyderabad, India Business-sector Biotechnology-private; Website http://www.indimmune.com 10. Wockhardt Ltd. Established in the year 1960 Wockhardt Ltd. is an international manufacturer of biopharmaceutical formulations along with Active Pharmaceutical Ingredients (API). An integrated multi-technology capability was developed by the company for manufacturing all types of dosage formulation that includes sterile injectables and lyophilised products. Chairman Habil Khorakiwala; Corporate Office Mumbai, India; Business Sector Biotechnology and Pharmaceutics-private Website http://www.wockhardt.com

View original post here:
Top 10 biotech companies and Top 100 biotechnology places ...

Biotechnology is the use of biological processes, organisms, or systems to manufacture products intended to improve the quality of human life. The earliest biotechnologists were farmers who developed improved species of plants and animals by cross pollenization or cross breeding. In recent years, biotechnology has expanded in sophistication, scope, and applicability.

The science of biotechnology can be broken down into subdisciplines called red, white, green, and blue. Red biotechnology involves medical processes such as getting organisms to produce new drugs, or using stem cells to regenerate damaged human tissues and perhaps re-grow entire organs. White (also called gray) biotechnology involves industrial processes such as the production of new chemicals or the development of new fuels for vehicles. Green biotechnology applies to agriculture and involves such processes as the development of pest-resistant grains or the accelerated evolution of disease-resistant animals. Blue biotechnology, rarely mentioned, encompasses processes in marine and aquatic environments, such as controlling the proliferation of noxious water-borne organisms.

Biotechnology, like other advanced technologies, has the potential for misuse. Concern about this has led to efforts by some groups to enact legislation restricting or banning certain processes or programs, such as human cloning and embryonic stem-cell research. There is also concern that if biotechnological processes are used by groups with nefarious intent, the end result could be biological warfare.

Also see nanotechnology and genetic engineering .

This was last updated in May 2007

Go here to read the rest:
What is biotechnology? - Definition from WhatIs.com

AP Industry Mission @ automobile,Agriculture, agri-biotech,biotechnology,IT,Pharmaceuticals,pharma
please note:poor quality video Release by I PR Department of AP ................................................................................................ The launch of Industry Mission...

By: VIZAG NEWS

See the original post:
AP Industry Mission @ automobile,Agriculture, agri-biotech,biotechnology,IT,Pharmaceuticals,pharma - Video

Biotechnology getting raked $IBB $AMGN $ALXN $BIIB $CELG $ILMN
When a hot sector turns, you don #39;t want to be in it. Biotechnology has been the hottest of hot as this market has climbed higher moving some 300% higher over the past three years. Phenomenal...

By: LA Little

View original post here:
Biotechnology getting raked $IBB $AMGN $ALXN $BIIB $CELG $ILMN - Video

Endoret (PRGF) BTI Biotechnology Institute
Endoret (PRGF) BTI Biotechnology Institute United Kingdom.

By: Castle Hill Clinic

Original post:
Endoret (PRGF) BTI Biotechnology Institute - Video

Biotechnology (B.S.) at FGCU
Students in the B.S. in Biotechnology program will gain an understanding of living organisms at the cellular and molecular level. The curriculum emphasizes hands-on learning and provides undergrad.

By: fgcu

Read this article:
Biotechnology (B.S.) at FGCU - Video

BLACK OPS 3 OFFICIAL TRAILER BREAKDOWN BIOTECHNOLOGY CONFIRMED COD BO3
black ops 3,black ops 3 teaser,black ops 3 trailer,black ops 3 gameplay,call of duty black ops 3,call of duty black ops 3 teaser,call of duty black ops 3 trailer,call of duty black ops 3 gameplay,c...

By: MrLolAleshka Let #39;s Play

Continued here:
BLACK OPS 3 OFFICIAL TRAILER BREAKDOWN BIOTECHNOLOGY CONFIRMED COD BO3 - Video

The Samba Of Shamba PT 2: Biotechnology

By: Kenya CitizenTV

Original post:
The Samba Of Shamba PT 2: Biotechnology - Video

Biotechnology at Tweed
animation created by: agence zigzag based on an original idea

By: Jean-Paul Lorand, Scientific Director of Tweed laboratory editorial committee and scenario: Groupe Nutriset / Odet / agence...

By: Agence zigzag

Go here to see the original:
Biotechnology at Tweed - Video

Biotechnology Department
Professor Dhanapalan College Of Arts And Science - Department of Biotechnology.

By: Dhanapalan College

Read more:
Biotechnology Department - Video

Editors note:Doug Edgeton, President and CEO of the North Carolina Biotechnology Center.

RESEARCH TRIANGLE PARK For the better part of four decades, North Carolina has steadily committed resources to developing biotechnologies and a life science cluster via the North Carolina Biotechnology Center. Through the work of many researchers, entrepreneurs, service providers, state and federal policy makers, and partners, North Carolina has grown its life science cluster from a handful of companies to 735 today.

As we begin to bridge our fifth decade of work, this National Biotechnology Month is an opportunity to show pride in the 66,000 people who make their living in this clean industry.

From the minds of North Carolina researchers, important advances still improve our quality of life today. North Carolinas prize-winning science brought us a model to study a broad spectrum of disease, a method for improving crop yield, and a contrarian yet correct approach to treating Alzheimers.

Today, North Carolina companies produce a range of medicines, diagnostic tests, improved crops and bio-based fuel that influence our lives every day. And in the coming decade North Carolina will lead the way with both the science behind and production of potentially curative gene and cell therapies.

Speakers at the 35th anniversary of the NC Biotech Center included, left to right: Aaron Lazarus, Doug Edgeton, John Rabby, Karen LeVert, Mary Beth Thomas, Bill Bullock. Photo by SP Murray for NC Biotech.

North Carolina has done this with a focus on raising up its population with world-class training programs, emulated across the U.S. and even internationally. With a combination of community college and university training, North Carolinians in both urban and rural areas are able to secure these high-paying jobs manufacturing important products in a clean environment. Nowhere is this better seen than in the BioPharma Crescent, a five-county area of rural eastern North Carolina. Through deliberate attention to infrastructure and training, this region has built a cluster of companies that employs 10,000 from a wide swath of rural North Carolina.

Biotechnology has made a similar positive impact on our states historic strength of agriculture. Cotton, soybeans and corn dominate the Coastal Plain, while underground North Carolina produces the worlds largest supply of sweet potatoes. A vast diversity of plants in western North Carolina provides the source for nutritional supplements. Our specialty crop farmers benefit from targeted research, and a consortium of researchers are uncovering new sources of animal feed with enhanced nutrition, grown right here in North Carolina.

In Kannapolis, researchers from a broad coalition of universities are matching nutrition, physical performance and longevity to extend the quality and length of lives.

The list of opportunities those realized and those yet to be goes on. From a trailer on the University of North Carolina at Chapel Hill campus came the global contract research and testing industry. In Winston-Salem, a biotech campus rose from a cluster of tobacco facilities. And for retiring veterans and high school seniors alike, targeted programs are opening up new opportunities for pharmaceutical manufacturing jobs.

Biotechnology and the life sciences have a long and broad history in North Carolina. On behalf of the North Carolina life science community, the North Carolina Biotechnology Center looks forward to the coming decade, to catalyzing the solutions that will make life better for North Carolinians, Americans, and people around the globe. With so much success behind us, there can only be greater promise ahead.

Here is the original post:
NC Biotech CEO Doug Edgeton: 'We will lead science behind curative gene, cell therapies" - WRAL Tech Wire

The Master's in Biotechnology Program is a Professional Science Master's Program, approved by the Council of Graduate Schools. This application focused graduate program is designed to train students in biotechnology. We are preparing the next generation of leaders in biotechnology.

This Section Contains

Our graduates are:

TOP

Biotechnology is a multidisciplinary endeavor that increasingly requires employees fluent in both science and business to enable the development of new technologies and products based on the unique applications of the cellular and molecular life sciences. The Master's Degree in Biotechnology at the California State University, Fresno offers students, who are fundamentally educated in various scientific disciplines, the opportunities to acquire the knowledge and skills required to comprehend and commercialize these emerging technologies and/or their products.

TOP

TOP

As a leading university in the Central Valley, California State University, Fresno will lead the way for new and innovative applications of biotechnology both in the state and throughout the nation.

TOP

Read more here:
Biology: MS in Biotechnology - California State University ...

G R O U P S T A T S

When it comes to advanced scientific degrees, we field the largest biotechnology group in New England 36 members, over 80% of whom have PhDs or MDs. We aggressively recruit people who develop advanced technology, and who speak the language of inventors and scientists, quickly grasping complex biotechnology matters.

Our clients include both large and emerging biotech companies such as Biogen, Dyax Corporation, and Lantheus Medical Imaging, privately financed startup companies,and prestigious academic and research institutions, including MIT, Dana Farber Cancer Institute, and Harvard Medical School. We understand the different needs of each client and bring practical solutions to the table.

Our expertise is broadand deep, covering areas from antibodies to transgenic technologiesand everything inbetween. We also call on members of our other practice groups includingChemical & Materials Technologies and Pharmaceuticalwhen their specialized expertise will benefit a clients project. In addition, our teams routinely include support from our paralegal group and our International Filing Department to contain costs and deliver value.

Our group's services include: IP strategic planning; patent portfolio development, acquisition, and enforcement; studies on patentability, infringement, and validity; IP audits and due diligence; licensing and technology transfer; defending and challenging patent validity, including post-grant proceedings; and freedom to operate and competitor analyses.

Representative clients:

For older news items, please go to News & Events.

Laura Vogel presents at ACI Conference

Wolf Greenfield and Client Cold Spring Harbor Laboratory Prevail in 4 IPRs

A.J. Tibbetts and Ed Walsh Present at BBA's 16th Annual Intellectual Property Year in Review

Wolf Greenfield Welcomes Counsel Laura Vogel

Wolf Greenfield and Client BTG Reach Favorable Outcome in IPR for CroFab Rattlesnake Antivenom Patent

LMG Life Sciences Recognizes Wolf Greenfield

Wolf Greenfield Welcomes Shareholder Jeffrey Hsi, Expert in Technology Commercialization

Wolf Greenfield Recognized in 2016 "Best Law Firms" Rankings

23 Wolf Greenfield Attorneys Named to 2015 Massachusetts Super Lawyers List

24 Wolf Greenfield Lawyers Named to 2015 Massachusetts Rising Stars List

Oona Johnstone interviewed by ASHG for Featured Chat Fridays

Managing IP Magazine Recognizes Wolf Greenfield

Favorable Outcome for BTG in Snake Antivenom ITC Investigation

Chelsea Loughran talks about CRISPR in Xconomy

20 Wolf Greenfield Lawyers Named to 2014 Massachusetts Rising Stars List

22 Wolf Greenfield Attorneys Named to 2014 Massachusetts Super Lawyers List

Pat Granahan comments on the battle to own CRISPR

Pat Granahan and Chelsea Loughran quoted on CRISPR-Cas in Nature Biotechnology

Patrick Waller interviewed by Radio Entrepreneurs

GenomeWeb quotes Chelsea Loughran on IP landscape surrounding CRISPR-Cas9

Wolf Greenfield Recognized by Managing IP Magazine

Chelsea Loughran quoted in The Scientist on first awarded CRISPR-Cas9 patent

Chelsea Loughran quoted in MIT Tech Review on first awarded patent for engineered CRISPR-Cas9 system

Doug Wolf featured as the Entrepreneur.com expert for the month of March

G R O U P S T A T S

When it comes to advanced scientific degrees, we field the largest biotechnology group in New England 36 members, over 80% of whom have PhDs or MDs. We aggressively recruit people who develop advanced technology, and who speak the language of inventors and scientists, quickly grasping complex biotechnology matters.

Our clients include both large and emerging biotech companies such as Biogen, Dyax Corporation, and Lantheus Medical Imaging, privately financed startup companies,and prestigious academic and research institutions, including MIT, Dana Farber Cancer Institute, and Harvard Medical School. We understand the different needs of each client and bring practical solutions to the table.

Our expertise is broadand deep, covering areas from antibodies to transgenic technologiesand everything inbetween. We also call on members of our other practice groups includingChemical & Materials Technologies and Pharmaceuticalwhen their specialized expertise will benefit a clients project. In addition, our teams routinely include support from our paralegal group and our International Filing Department to contain costs and deliver value.

Our group's services include: IP strategic planning; patent portfolio development, acquisition, and enforcement; studies on patentability, infringement, and validity; IP audits and due diligence; licensing and technology transfer; defending and challenging patent validity, including post-grant proceedings; and freedom to operate and competitor analyses.

Representative clients:

For older news items, please go to News & Events.

Laura Vogel presents at ACI Conference

Wolf Greenfield and Client Cold Spring Harbor Laboratory Prevail in 4 IPRs

A.J. Tibbetts and Ed Walsh Present at BBA's 16th Annual Intellectual Property Year in Review

Wolf Greenfield Welcomes Counsel Laura Vogel

Wolf Greenfield and Client BTG Reach Favorable Outcome in IPR for CroFab Rattlesnake Antivenom Patent

LMG Life Sciences Recognizes Wolf Greenfield

Wolf Greenfield Welcomes Shareholder Jeffrey Hsi, Expert in Technology Commercialization

Wolf Greenfield Recognized in 2016 "Best Law Firms" Rankings

23 Wolf Greenfield Attorneys Named to 2015 Massachusetts Super Lawyers List

24 Wolf Greenfield Lawyers Named to 2015 Massachusetts Rising Stars List

Oona Johnstone interviewed by ASHG for Featured Chat Fridays

Managing IP Magazine Recognizes Wolf Greenfield

Favorable Outcome for BTG in Snake Antivenom ITC Investigation

Chelsea Loughran talks about CRISPR in Xconomy

20 Wolf Greenfield Lawyers Named to 2014 Massachusetts Rising Stars List

22 Wolf Greenfield Attorneys Named to 2014 Massachusetts Super Lawyers List

Pat Granahan comments on the battle to own CRISPR

Pat Granahan and Chelsea Loughran quoted on CRISPR-Cas in Nature Biotechnology

Patrick Waller interviewed by Radio Entrepreneurs

GenomeWeb quotes Chelsea Loughran on IP landscape surrounding CRISPR-Cas9

Wolf Greenfield Recognized by Managing IP Magazine

Chelsea Loughran quoted in The Scientist on first awarded CRISPR-Cas9 patent

Chelsea Loughran quoted in MIT Tech Review on first awarded patent for engineered CRISPR-Cas9 system

Doug Wolf featured as the Entrepreneur.com expert for the month of March

Some areas of expertise

Read more from the original source:
Biotechnology | Wolf Greenfield

The work of the Biology and Biotechnology Department at WPI goes far beyond the theoretical. Students, faculty, and industry collaborate in research and discovery to solve problems that affect us all. Their goals: to help treat and cure common, dread diseases, like Alzheimers and cancer; heal wounds faster; create a greener world through science; and use computer science techniques to solve flesh-and-blood problems.

And weve only scratched the surface of what the Biology and Biotechnology Department is doing. Its state-of-the-art new research center, the Life Sciences and Bioengineering Center at Gateway Park, is practically bursting at the seams with fundamental and applied research, conducted with cutting-edge instrumentation and tools. Here, graduate and select undergraduate students work across disciplines and with companies in the field.

Graduates of the Biology and Biotechnology Department at WPI go on to myriad careers in industry and academia, across organizations large and small. And the research interests of our faculty encompass a similarly large range.

Its an exciting time for the life sciences. We invite you to learn more about how the Biology and Biotechnology Department can help you reach your educational and career goals.

Assistant Professor Luis Vidali describes his collaboration with Assistant Professor Erkan Tuzel of the Department of Physics to investigate cell biology and help develop a more active biophysics program at WPI.

More here:
Biology & Biotechnology - WPI

Latest Articles

Efforts to expand use of biotechnology to crops other than corn, soybeans, cotton and canola have been hindered by opposition from consumer and environmental groups.

By ANDREW POLLACK

Federal officials have approved a cheaper version of Johnson & Johnsons blockbuster drug Remicade, a biotech medicine for inflammatory diseases.

General Mills said on Friday that it would start labeling all products that contain genetically modified ingredients to comply with a law set to go into effect in Vermont.

The salary, bonus and stock awards given to Fords chief executive, Mark Fields, jumped 17 percent in 2015.

The senators will consider whether the government should require labeling on foods containing genetically engineered ingredients, an issue that has split the food industry.

By JENNIFER STEINHAUER and STEPHANIE STROM

A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But thats just a start.

By ANDREW POLLACK

States should be free to require the labeling of genetically modified food if they want to.

By THE EDITORIAL BOARD

Bioengineers at Rice University recently found that different drops from single fingerpricks on multiple subjects varied substantially.

By DONALD G. McNEIL Jr.

With the success of growing the body parts in a lab, bioengineers are taking a step toward creating replacement organs that can be transplanted into people.

By NICHOLAS ST. FLEUR

Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,

The two biotech companies initial public offerings are testing the waters after a recent sell-off in biotech.

Businesses allow parents to leverage their wealth, contacts and the hope of investors to jump-start research into the diseases that afflict their children.

By PAUL SULLIVAN

Scientists have shown that DNA molecules can be the basis for a long-term storage system potentially capable of holding all of the worlds digital information in a tiny space.

By JOHN MARKOFF

The herbicide, which contains the old herbicide 2,4-D, was to be used on crops genetically modified to be resistant to it.

The Food and Drug Administration said that the salmon would not have to be labeled as genetically engineered, consistent with its broader stance on widely eaten genetically modified foods.

Senator Orrin G. Hatch objects to language that would limit brand-name drug makers monopoly protections abroad for their cutting-edge medicines known as biologics.

By JACKIE CALMES

The case is significant because it indicates that cell therapies might not have to be customized for each patient.

By ANDREW POLLACK

An irrational phobia of genetically modified crops is causing real harm.

By MARK LYNAS

A confluence of factors, including Chinas slowing growth, falling commodity prices and trouble in the biotech sector, sent the markets lower.

Readers explain why they disagree with Dr. Ezekiel J. Emanuels proposed solutions for rising drugs costs.

Efforts to expand use of biotechnology to crops other than corn, soybeans, cotton and canola have been hindered by opposition from consumer and environmental groups.

By ANDREW POLLACK

Federal officials have approved a cheaper version of Johnson & Johnsons blockbuster drug Remicade, a biotech medicine for inflammatory diseases.

General Mills said on Friday that it would start labeling all products that contain genetically modified ingredients to comply with a law set to go into effect in Vermont.

The salary, bonus and stock awards given to Fords chief executive, Mark Fields, jumped 17 percent in 2015.

The senators will consider whether the government should require labeling on foods containing genetically engineered ingredients, an issue that has split the food industry.

By JENNIFER STEINHAUER and STEPHANIE STROM

A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But thats just a start.

By ANDREW POLLACK

States should be free to require the labeling of genetically modified food if they want to.

By THE EDITORIAL BOARD

Bioengineers at Rice University recently found that different drops from single fingerpricks on multiple subjects varied substantially.

By DONALD G. McNEIL Jr.

With the success of growing the body parts in a lab, bioengineers are taking a step toward creating replacement organs that can be transplanted into people.

By NICHOLAS ST. FLEUR

Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,

The two biotech companies initial public offerings are testing the waters after a recent sell-off in biotech.

Businesses allow parents to leverage their wealth, contacts and the hope of investors to jump-start research into the diseases that afflict their children.

By PAUL SULLIVAN

Scientists have shown that DNA molecules can be the basis for a long-term storage system potentially capable of holding all of the worlds digital information in a tiny space.

By JOHN MARKOFF

The herbicide, which contains the old herbicide 2,4-D, was to be used on crops genetically modified to be resistant to it.

The Food and Drug Administration said that the salmon would not have to be labeled as genetically engineered, consistent with its broader stance on widely eaten genetically modified foods.

Senator Orrin G. Hatch objects to language that would limit brand-name drug makers monopoly protections abroad for their cutting-edge medicines known as biologics.

By JACKIE CALMES

The case is significant because it indicates that cell therapies might not have to be customized for each patient.

By ANDREW POLLACK

An irrational phobia of genetically modified crops is causing real harm.

By MARK LYNAS

A confluence of factors, including Chinas slowing growth, falling commodity prices and trouble in the biotech sector, sent the markets lower.

Readers explain why they disagree with Dr. Ezekiel J. Emanuels proposed solutions for rising drugs costs.

Read the original here:
Biotechnology - The New York Times

PROGRAM DESCRIPTION

The Master of Science in Biotechnology program in the College of Medicine will prepare students to function in the industrial biotechnology environment. This program is designed to give students broad knowledge and training in the scientific and practical aspects of biotechnology.

The Master of Science in Biotechnology program in the College of Medicine will prepare students to function in the industrial biotechnology environment. This program is designed to give students broad knowledge and training in the scientific and practical aspects of biotechnology.

It involves innovative, hands-on and multidisciplinary learning approaches to educate and train students in scientific aspects of biotechnology. The courses and research training required of all students in this program are designed to develop independent thinking, team work and communication skills, which are highly desirable in the biotechnology industry. Students will be provided an industrial perspective and an understanding of product development at the same time as they are trained in the biotechnology techniques required for such development.

The Master of Science in Biotechnology program consists of a minimum of 30 semester credit hours of graduate courses offeredby the Burnett School of Biomedical Sciences inthe College of Medicine that includes 21 credit hours minimum of required courses, 3 credits of restricted electives,and 6 credit hours of thesis research as detailed below.

What makes this program unique is the focus on practical training offered to graduate students through masters thesis research in molecular biotechnology to perform jobs in laboratory environment that require scientific talent.

Students must take the following courses plus at least two credit hours of graduate seminar.

MCB 5722C Methods in Biotechnology (4 credit hours) or BSC 6407C Laboratory Methods in Molecular Biology (3 credit hours)

BSC 6432 Structure-Function-Relationships of Biomedical Sciences I (5 credit hours)

BSC 6433 Structure-Function-Relationships of Biomedical Sciences II (5 credit hours)

BSC 6431 Practice of Biomedical Sciences (3 credit hours)

PCB 5527 Genetic Engineering and Biotechnology (3 credit hours) or one of the following: BSC 5418 Tissue Engineering (3 credit hours), MCB 6417C Microbial Metabolism (3 credit hours), PCB 5025 Molecular and Cellular Pharmacology (3 credit hours)

Students will participate in at least two graduate seminar courses thatwill prepare them for making professional presentations with emphasis in biotechnology. The courseswill involve participation of speakers from the biotechnology industry with emphasis on an industrial perspective on biotechnology applications and product development.

Students willselect three credit hours of restricted electives from the list below.

Students will take a minimum of six credits of thesis research (MCB 6971) to complete their research and submit their thesis specializing in biotechnology research. Students are expected to have an in-depth discussion with at least three faculty members before choosing alaboratory for thesis research.The student and the Thesis Adviser/Major Professor will jointly recommend an advisory committee comprised of at least three members. The committee composition must reflect expertise relevant to the students thesis research and must be approved by the Graduate Committee. Students switching to change the composition of the Thesis Advisory Committee must also obtain approval from the Graduate Committee.

The thesis proposal defense requirement should be met and passed successfully no later than the end of the summer of the first year in the program. Students will not be allowed to register for courses for the Fall semester of their second year until this requirement is fulfilled. The Thesis Proposal requirement includes: 1) a written 5-page thesis proposal; 2) a thesis proposal defense in front of the thesis committee; and 3) questions by the thesis committee to test the student's understanding of the basic concepts in the field and relevant applications. The student will be evaluated on performance in all three sections. Should the student fail, a second opportunity will be provided within 2 weeks of the first attempt. A second failure will result in dismissal from the program.

An oral thesis defense is required. The defense will be in the format of:

A 50-minute presentation of the thesis work, including a 5-minute introduction

A 10-minute free period for the general audience to ask questions

A 1-hour closed-door examination by the Thesis Advisory Committee and the program faculty present

The thesis should be of significant scope and depth such that the work has made advances in the area of biotechnology. The MS thesis research must generate sufficient quantity and quality data to support the submission of a minimum of one manuscript. Approval of the final thesis will require consent from the majority of the Program Faculty who choose to review the thesis, inclusive of the Thesis Advisory Committee. Faculty members with dissenting vote on the thesis must provide written justification. Scientific journal review criteria will be used as guidelines by the faculty to evaluate the final thesis for its appropriateness for publication in the target journal.

Students will be evaluated on the progress in thesis research by the thesis advisory committee for fall and spring. Two consecutive unsatisfactory evaluations will result in dismissal from the program.

Students must pass a comprehensive exam to qualify for the Master of Science degree.

Students must successfully pass an oral comprehensive examination to test the understanding of the basic concepts in the field and relevant applications. The Comprehensive Examination will be conducted during the thesis proposal defense.The exam will be administered by the thesis committee. Should the student fail this exam, a second opportunity will be provided within 2 weeks of the first attempt. A second failure will result in dismissal from theprogram.

For information on general UCF graduate admissions requirements that apply to all prospective students, please visit theAdmissions section of the Graduate Catalog.Applicants mustapply online. All requested materials must be submitted by the establisheddeadline.

In addition to thegeneral UCF graduateapplication requirements, applicants to this program must provide:

Personal interviews are helpful but not required. Applicants whodo not have a competitiveGPA or GRE may occasionally be accepted if there is other convincing evidence of potential for high achievement and success.

Applicants who hold a BS degree in unrelated fields are expected to have the equivalent of 16 semester hours of credit in the biotechnology/biological sciences including a course in general microbiology, biochemistry or molecular biology or cell biology, plus one year of organic chemistry, one year of physics, basic university mathematics and statistics, and laboratory skills equivalent to the minimum required of our own undergraduates. Minor deficiencies may be remedied after acceptance by enrollment at the first opportunity in an appropriate course.

-

-

-

-

-

-

Fellowships are awarded based on academic merit to highly qualified students. They are paid to students through the Office of Student Financial Assistance, based on instructions provided by the College of Graduate Studies. Fellowships are given to support a students graduate study and do not have a work obligation. For more information, see UCF Graduate Fellowships, whichincludes descriptions of university fellowshipsand what you should do to be considered for a fellowship.

Read the original:
Biotechnology MS Degree - UCF Graduate Catalog 2016-2017

Updated: 2016-02-29

CSC Pharmaceuticals International

Listed in Pharmaceutical Drugs

(91)-(22)-65302901

Padhya Building, 2nd Floor, 11, Bhaskar Bhau Lane, Gamdevi Mumbai - 400007, Maharashtra, India

Description: CSC Pharmaceuticals International, Mumbai, India We, CSC Pharmaceuticals are offering Indian pharmaceutical drugs, pharmaceutical health Read more...

Updated: 2015-08-12

admin

09810663976

D 2/2, Ganga Triveni Apartments, Sector 9, Rohini New Delhi - 110085 Delhi, India

Description: G V Biomedicals, New Delhi, Delhi, India Supplier of Biotechnology & Biomedical Products. With a Read more...

Updated: 2015-08-12

admin

+91-11-24636224 /11-24636225

824/3, Sukhdev Nagar, Kotla Mubarakpur, New Delhi 110003, India

Description: TechnoConcept (India) Pvt. Ltd., New Delhi, Delhi, India Supplier of Bioinformatics Software and Molecular Biology Read more...

Updated: 2015-08-11

admin

+91(22)43434545, 43434535

1st Floor, SaneGuruji Building, Veer Sawarkar Marg, Opposite Siddhivinayak Temple, Prabhadevi, Mumbai (Suburban), Maharashtra, India

Description: Indian Dental Association, Mumbai, Maharashtra, India Independent and Recognized Voice of Dental Professionals. The Indian Read more...

Updated: 2015-08-11

admin

+91-120-4292758

Description: GenPro Biotech, Noida, Uttar Pradesh, India Supplier of Chemicals. GenPro Biotech was founded about a Read more...

Updated: 2015-08-10

admin

+91 80 4262 7200

75A, 15th Cross, 1st Phase, J.P.Nagar, Bangalore - 560078

Description: Semler Research Center, Bangalore, Karnataka, India Service Provider. Semler Research Center (SRC) is part of Read more...

Updated: 2015-08-10

admin

(+91)-11-45035753, (+91)-11-28753658

Building NO: 1333, 4th Floor, Office No:412, Durga Chamber, Desh Bandhu Gupta Road, Karol Bagh, New Delhi- 110005. (India)

Description: Biolinkk, New Delhi, Delhi, India Supplier of Products & Services to Life Science Research, Industrial Read more...

Updated: 2015-08-08

admin

91-11-27677960, 27674615, 27670742, +91-11-47020100

A-2/3, IIIrd Floor, Lusa Tower, Azadpur Commercial Complex, Delhi-110033, India

Description: Titan Biotech Limited, New Delhi, Delhi, India Providing good quality of Biological Products. TITAN BIOTECH Read more...

Updated: 2015-08-08

admin

1-631-559-9269 Fax: 1-631-938-8127

45-16 Ramsey Road, Shirley, NY 11967, USA

Description: Creative Biomart, New York, USA Product Development and Distribution. Creative Biomart provides quality recombinant proteins, Read more...

Updated: 2015-08-06

admin

+91-0171-2643080 , 2601773

Guru Nanak Gurdwara, New Pratap Nagar, Ambala, Haryana 134003, India

Description: Company Manufacturer & Supplier of Scientific and Laboratory Equipment. Scientific instrumentation industry has been playing Read more...

Updated: 2016-02-09

Added by PharmaTechnologyIndex.com Pvt Ltd

Categories: Equipments, Technology

October 30, 2015, October 31, 2015, November 1, 2015

Plot No. 5, Part II, Scheme No 78, Near Life Care Hospital, Vijay Nagar, Indore, Madhya Pradesh 452010

91 987 961 6665

Description: PharmaTech Expo, Indore, India PharmaTechnologyIndex.com Pvt. Ltd, a KNS group company is delighted to invite Read more...

Updated: 2015-10-16

Added by Messe Dusseldorf GmbH

Categories: Equipments

November 16, 2015, November 17, 2015, November 18, 2015

P.O.B. 10 10 06, D-40001 Duesseldorf Stockumer Kirchstrae 61, D-40474 Duesseldorf, Germany

49 (0)211 / 4560-7618

Description: Compamed, Dusseldorf, Germany Compamed 2015 is one of the finest event for the medical fraternity. Read more...

Updated: 2015-11-13

Added by we.CONECT Global Leaders GmbH

Categories: Technology

November 16, 2015, November 17, 2015

Los-Angeles-Platz 1, 10789 Berlin, Germany

49 (0)30 52 10 70 3 0

Description: Pharma M2R Minds, Berlin, Germany Maintenance processes in the pharmaceutical industry are subject to very Read more...

Updated: 2015-11-09

Added by Imapac Media

Categories: Biotechnology

November 17, 2015, November 18, 2015

Tel Aviv, Israel

65 3109 0121

Description: Biologics World Israel, Tel Aviv, Israel The environment of innovation and entrepreneurship in Israel has Read more...

Updated: 2015-11-12

Added by BioGenesis Conferences

Categories: Technology

November 18, 2015, November 19, 2015, November 20, 2015

J.N.Tata Auditorium, Indian Institute of Sciences Bengaluru, India

Description: Global Cancer Summit, Bangalore, India The conference will cover areas like prevention, early diagnosis, economics Read more...

Updated: 2016-02-09

Added by Japan Management Association

Categories: Equipments

November 25, 2015, November 26, 2015, November 27, 2015

3-11-1 Ariake, Koto-ku, Tokyo, Japan

81-3-3434-1988

Description: Hospex Japan, Tokyo, Japan Hospex Japan 2015 is an International Healthcare Engineering Exhibition. The show Read more...

Updated: 2015-11-16

Added by Cogora Limited

Categories: Technology

November 26, 2015

24-26 Newport Rd, Cardiff, South Glamorgan CF24 0DD, United Kingdom

44 (0)207 214 0693

Description: Nursing in Practice, Cardiff, UK Nursing in Practice will be returning to Cardiff this year Read more...

Updated: 2015-11-19

Added by Worldwide Business Research

Original post:
Home - Biotechnology Business Directory